Polypeptide, lipoprotein-like nano particle and application thereof
A nanoparticle and lipoprotein technology, applied in apolipoproteins, fusion polypeptides, animal/human proteins, etc., can solve the application limitations of high-density lipoprotein nanoparticles, high cost of ApoA-I protein synthesis, difficult functional modification, etc. problem, to achieve the effect of multi-function, high stability and easy functionalization
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0107] In the lipoprotein-like nanoparticles based on the helix-loop-helix structure polypeptide of this embodiment, the helix-loop-helix structure polypeptide (ALA polypeptide) is composed of an α-helix polypeptide, a cyclization sequence and an α-helix polypeptide in the form of a covalent bond concatenated. Wherein the amino acid sequence of the α-helical polypeptide is: GSFLSALEEWTKKLN, but it is not limited to this sequence. The cyclized polypeptide sequences are respectively SGS, SGSGS, and SGSGSGS, but are not limited to this sequence, and may also be other sequences with specific functions.
[0108] One of the AL 5 The synthesis process of A polypeptide is as follows: adopt solid-phase synthesis method (refer to literature 1 and literature 2), use Fmoc amino acid, dichlorotrityl resin as carrier, carry out the sequence from C-terminal to N-terminal on it according to the designed sequence Amino acid condensation reaction, after the last amino acid in the polypeptide ...
Embodiment 2
[0120] According to embodiment 1 result shows the synthetic AL 3 A.AL 5 A.AL 7 A polypeptide can successfully stabilize lipoprotein-like nanoparticles. In this example, the drug-loading ability of lipoprotein-like nanoparticles was studied. to AL 3 A peptide was taken as an example to study. In this embodiment, the steps of the method for preparing lipoprotein-like nanoparticles and the amount of reactants are basically the same as in Example 1, except that 3 μmol DMPC, 0.15 μmol cholesteryl lipid (Cholesteryl oleate, CO for short), 0.2μmol Ir(ppy) 2-DIP in chloroform. Filling the hydrophobic core of lipoprotein-like nanoparticles with the fluorescent and toxic compound Ir(ppy) 2 -DIP. Figure 12 and Figure 13 Show AL 3 A-LNP coated with Ir(ppy)2-DIP can still form lipoprotein-like nanoparticles (AL 3 A-LNP(Ir)). Figure 14 Packaged Ir(ppy) in storage environment as shown 2 -DIP of A-LNP unstable, 48 hours Ir(ppy) 2 -DIP release up to 50%. Package Ir(ppy) 2 -D...
Embodiment 3
[0122] In this example, the -HHHHH- sequence with specific functions was inserted into the circularized structure for functional research. In this example, lipoprotein-like nanoparticles (A(His) 5 A-LNP (Ir)) preparation method steps and the amount of reactants are basically the same as in Example 2, the difference is that in step (6), the helix-loop-helix polypeptide is A(His) 5 a. After step (6), the lipoprotein-like nanoparticles were purified with a 100K ultrafiltration tube to remove free molecules. Detection by DLS and TEM, the results showed that the package Ir(ppy) 2 -A(His) of DIP 5 A-LNP forms nanoparticles with uniform particle size, see Figure 15-Figure 16 . A(His) 5 After A-LNP(Ir) was purified by ultrafiltration, the peptide was quantified, and then incubated with a certain amount of Ni column at room temperature for 1 hour, centrifuged, and the supernatant was sucked for fluorescence detection. Figure 17 It shows that when the cyclic sequence is HHHHH, ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com